β Home
© 2024 - 2025 InsightfulValue.com. All rights reserved.
βΉοΈ Info
π§Ύ At a Glance π Core Facts ποΈ Products/Services β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π Insights π’ Company Q&A (464) π οΈ Industry Q&A (98) π Competitors π Price Low π Price Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risk Assessment π§© Segmentation π Ά Google Linksπ Ratios
π° Margins π Financial Ratios π± Growth π Enterprise Value π Key Metrics π΅ Dividendsπ§ Tools
β Due DiligenceποΈ SEC Filings
Date accepted | Link | Final link |
---|---|---|
2025-04-30 17:00:57 | SC TO-C | SC TO-C final |
2025-04-29 06:01:32 | 6-K | 6-K final |
2025-04-02 21:35:17 | 6-K | 6-K final |
2025-03-28 14:01:26 | 6-K | 6-K final |
2025-01-31 07:16:07 | 6-K | 6-K final |
2025-01-31 07:14:14 | ***** | ***** |
2025-01-31 07:12:21 | ***** | ***** |
2025-01-31 07:07:54 | ***** | ***** |
2024-12-30 06:05:06 | ***** | ***** |
2024-11-25 10:20:04 | ***** | ***** |
2024-10-29 16:07:44 | ***** | ***** |
2024-10-29 06:20:12 | ***** | ***** |
2024-10-17 16:01:28 | ***** | ***** |
2024-09-18 16:38:44 | ***** | ***** |
2024-09-17 17:08:15 | ***** | ***** |

π Explore more SEC filings for Novartis!
Sign up for free or log inπ₯ Get our free eBook now: "The Checklist Value Investor β A Smarter Way to Pick Stocks"